Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Vernalis plc    VER   GB00B3Y5L754

Delayed Quote. Delayed  - 04/29 05:35:02 pm
49.75 GBp   -0.50%
04/26 VERNALIS : Posting of Circular and Notice of General Meeting
04/26 UPDATE : Backed By CEO And Investors, Vernalis Raises GBP40 Million ..
04/26 VERNALIS : Eyes US Cough Cold Market With GBP40 Million Fundraising ..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
04/25/2016 04/26/2016 04/27/2016 04/28/2016 04/29/2016 Date
50(c) 50.25(c) 49.75(c) 50(c) 49.75(c) Last
52 439 66 647 28 493 3 235 551 748 784 Volume
-1.72% +0.50% -1.00% +0.50% -0.50% Change
More quotes
Financials ( GBP)
Sales 2016 12,6 M
EBIT 2016 -29,8 M
Net income 2016 -25,8 M
Debt 2016 12,2 M
Yield 2016 -
Sales 2017 27,7 M
EBIT 2017 -20,5 M
Net income 2017 -20,0 M
Debt 2017 3,23 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 18,5x
EV / Sales 2017 8,11x
Capitalization 221 M
More Financials
Company
Vernalis Plc engages in the research, development, and commercialization of pharmaceutical products under the Tuzistra XR brand.The company was founded by Keith G. McCullagh in 1986 and is headquartered in Winnersh, United Kingdom. 
More about the company
Surperformance© ratings of Vernalis plc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERNALIS PLC
04/26 VERNALIS : Posting of Circular and Notice of General Meeting
04/26 UPDATE : Backed By CEO And Investors, Vernalis Raises GBP40 Million (ALLISS)
04/26 VERNALIS : Eyes US Cough Cold Market With GBP40 Million Fundraising (ALLISS)
04/21 VERNALIS : Appoints Sandford Sommer as President & Chief Operating Officer, Vern..
04/21 VERNALIS : Sandford Sommer appointed as President & COO in US
04/21 VERNALIS : Taps AstraZeneca Veteran Sommer For US Business
04/14 VERNALIS : Says CCP-07 Study Completed, On Track For Application
04/14 VERNALIS : Announce CCP-07 Multiple-Dose Results
More news
Sector news : Biotechnology & Medical Research - NEC
04/29 SANOFI : offers to buy Medivation for $9.3bn
04/29 SANOFI : France's Sanofi makes $9.3 billion bid for US cancer drug giant
04/29DJSanofi Seeks Talks With Medivation Over $9.3 Billion Offer -- 2nd Update
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
03/17 Vernalis ADR reports 6M'15 results
2015 Vernalis acquires U.S. rights to extended-release antibiotic


Comments 
Advertisement
Chart VERNALIS PLC
Duration : Period :
Vernalis plc Technical Analysis Chart | VER | GB00B3Y5L754 | 4-Traders
Full-screen chart
Technical analysis trends VERNALIS PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions